Comparative study on the clinical use of protein S-100B and MIA (Melanoma Inhibitory Activity) in melanoma patients

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 5059-5063

  Schmitz, C ^a   Brenner, W ^a   Henze, E ^a   Christophers, E ^a   Hauschild, A ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Malignant melanoma; Melanoma inhibitory activity (MIA); Metastasis; Protein S 100B; Tumor marker

Indexed keywords

MELANOMA INHIBITORY ACTIVITY; PROTEIN S 100; PROTEIN S100B; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTIGEN DETECTION; CANCER STAGING; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; LUMINESCENCE; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; HUMANS; MELANOMA; NERVE GROWTH FACTORS; PROGNOSIS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0034451687     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. An analysis of prognostic factors in 8500 patients with cutaneous melanoma
2. Laboratory test and imaging studies in patients with cutaneous malignant melanomas: A survey of experienced physicians
3. Frequency and duration of patient follow-up after treatment of a primary malignant melanoma
4. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma
5. Prognostic significance of serum S-100B detection compared with routine blood parameters in advanced metastatic melanoma patients
6. Serum S-100 protein: A potentially useful prognostic marker in cutaneous melanoma
7. Melanoma inhibitory activity, a novel serum marker for progression of malignant melanoma
8. A soluble protein characteristic of the nervous system
9. Structural relation of two S-100 proteins in bovine brain: Subunit composition of S100a protein
10. S100 protein: A marker for human malignant melanomas?
11. S-100 protein remains a practical marker for melanocytic and other tumors
12. Immunohistochemical study of melanocytic nevus and malignant against melanoma with monoclonal antibodies S-100 subunits
13. 2+-binding protein family
14. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100B-binding protein
15. Prognostic value of serum analysis of S-100B protein in malignant melanoma
16. The luminescence immunoassay S-100: A sensitive test to measure circulating S-100B: Its prognostic value in malignant melanoma
17. S-100B protein detection in serum is a significant prognostic factor in metastatic melanoma
18. Predictive value of serum S-100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy
19. Purification and analysis of growth regulating proteins secreted by a human melanoma cell line
20. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA
21. MIA (Melanoma Inhibitory Activity) biological functions and clinical relevance
22. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cell lines: Low levels of MIA mRNA are present in various cell types and in peripheral blood
23. MIA, a novel serum marker for progression of malignant melanoma